← Alle mensen

AV

Ana Vivancos

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analyse.
The Lancet. Oncology · 2025-08
Biomarkeranalyse van NALA: neratinib versus lapatinib bij HER2-positief mammacarcinoom
Clinical cancer research : an official journal of the American Association for Cancer Research · 1 november 2021